Hólyagrák: vizsgálatok itt: Kína
167 trials · From ClinicalTrials.gov, checked 2026. november 16.. Ask the study team whether a trial fits you.
- 3. fázisTaking peopleA Study to Evaluate 9MW2821 Versus Chemotherapy in Subjects With Previously Treated Locally Advanced or Metastatic Urothelial Cancer
- Where
- Shanghai
- Életkor
- 18 év to 75 év
- People
- 432
- Run by
- Mabwell (Shanghai) Bioscience Co., Ltd.
See details and how to joinNCT06196736 - 1. fázisTaking peoplePilot Study on Rutin Combined With Tislelizumab and GC (Gemcitabine and Cisplatin) as Neoadjuvant Therapy for Platinum-refractory Muscle-invasive Bladder Cancer
- Where
- Chongqing
- Életkor
- 18 év and over
- People
- 10
- Run by
- First Affiliated Hospital of Chongqing Medical University
See details and how to joinNCT06916494 - 2. fázisTaking peopleProbiotics in Advanced Urothelial Carcinoma
- Where
- Guangzhou, Wuhan
- Életkor
- 18 év and over
- People
- 222
- Run by
- Sun Yat-sen University
See details and how to joinNCT06904573 - 1. fázisTaking peopleIrinotecan Liposomes Combined with Epirubicin in Recurrent Non-muscle Invasive Bladder Urothelium Carcinoma After Anthracyclines Treatment
- Where
- Chongqing
- Életkor
- 18 év and over
- People
- 18
- Run by
- First Affiliated Hospital of Chongqing Medical University
See details and how to joinNCT06766266 - 2. fázisTaking people9MW2821 + Toripalimab vs 9MW2821 for 1st Line Locally Advanced or Metastatic Urothelial Carcinoma
- Where
- Changsha, Nanjing
- Életkor
- 18 év to 80 év
- People
- 60
- Run by
- Mabwell (Shanghai) Bioscience Co., Ltd.
See details and how to joinNCT06823427 - No phaseTaking peopleImmediate Chemotherapy Following Resection for High-Risk Non-Muscle-Invasive Bladder Cancer
- Where
- Shanghai
- Életkor
- 18 év and over
- People
- 72
- Run by
- Changhai Hospital
See details and how to joinNCT06889623 - No phaseTaking peopleA Bladder-Sparing Treatment Strategies of Large-Volume Non-Muscle-Invasive Bladder Cancer
- Where
- Nanjing
- Életkor
- 18 év to 80 év
- People
- 60
- Run by
- The First Affiliated Hospital with Nanjing Medical University
See details and how to joinNCT06735287 - No phaseTaking peopleThe Efficacy of Gallium[68Ga]NOTA-DNA Multivalent SGC8 Injection for Bladder Tumour Imaging
- Where
- Shanghai
- Életkor
- 18 év to 85 év
- People
- 20
- Run by
- RenJi Hospital
See details and how to joinNCT06763354 - 3. fázisNot yet taking people in KínaA Clinical Trail to Determine the Safety and Efficacy of the Combination of Tislelizumab With Cisplatin and Gemcitabine, With or Without Trilaciclib for Patients With Untreated Unresectable and Metastatic Urothelial Carcinoma.
- Where
- Changsha, Guangzhou, Wuhan
- Életkor
- 18 év and over
- People
- 210
- Run by
- Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
See details and how to joinNCT06364904 - 3. fázisTaking peopleInvestigating the Efficacy and Safety of Neoadjuvant Intravesical Instillation of Mitomycin C in Treating High-risk NMIBC Patients
- Where
- Wuhan, Xiangyang
- Életkor
- 18 év to 75 év
- People
- 180
- Run by
- Shaogang Wang
See details and how to joinNCT06696794 - 1/2. fázisTaking peopleA Study of SHR-1501 Alone or in Combination With BCG or SHR-1316 in Subjects With NMIBC
- Where
- Beijing
- Életkor
- 18 év and over
- People
- 150
- Run by
- Shanghai Hengrui Pharmaceutical Co., Ltd.
See details and how to joinNCT05410730 - No phaseTaking peopleUltrasound Contrast-Enhanced Accurate Diagnosis of Preoperative Staging of Bladder Cancer
- Where
- Guangzhou
- Életkor
- 18 év to 75 év
- People
- 480
- Run by
- Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
See details and how to joinNCT06775977 - 2. fázisTaking peopleA Study of RC48-ADC Combined with JS001 for Postoperative Adjuvant Treatment of Upper Tract Urothelial Carcinoma
- Where
- Nanjing
- Életkor
- 18 év and over
- People
- 30
- Run by
- Jinling Hospital, China
See details and how to joinNCT05917158 - 1. fázisTaking peopleA Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of SIM0237 Alone or in Combination with BCG in NMIBC
- Where
- Beijing, Changsha, Chengdu, Guangzhou, Haerbin, Jinan, Qingdao, Shanghai, Taiyuan, Tianjin, Wenzhou, Wuhan, Zhengzhou
- Életkor
- 18 év and over
- People
- 152
- Run by
- Jiangsu Simcere Pharmaceutical Co., Ltd.
See details and how to joinNCT06186414 - No phaseTaking peoplePreoperative Detection of Muscle Invasion in Bladder Cancer with Contrast-enhanced Ultrasonography
- Where
- Guangzhou
- Életkor
- 18 év to 75 év
- People
- 1000
- Run by
- Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
See details and how to joinNCT05204108 - 1/2. fázisTaking peopleSafety, Tolerability, and Preliminary Efficacy of BH011 in Subjects With Non-Muscle-Invasive Bladder Cancer
- Where
- Beijing, Changsha, Shanghai, Shenyang, Tianjin, Xiamen
- Életkor
- 18 év and over
- People
- 48
- Run by
- Zhuhai Beihai Biotech Co., Ltd
See details and how to joinNCT06732531 - 1. fázisTaking peopleA Phase I Clinical Study of SHR-2005 Intravesical Instillation in the Treatment of Intermediate and High-risk Non-muscle Invasive Bladder Cancer (NMIBC)
- Where
- Shanghai
- Életkor
- 18 év and over
- People
- 170
- Run by
- Shanghai Hengrui Pharmaceutical Co., Ltd.
See details and how to joinNCT06108492 - 2. fázisTaking peoplePD1 Inhibitors Combined With Clostridium Butyricum for Urothelial Carcinoma
- Where
- Nanjing
- Életkor
- 18 év and over
- People
- 60
- Run by
- The First Affiliated Hospital with Nanjing Medical University
See details and how to joinNCT06696742 - 2. fázisTaking peopleA Phase 2 Clinical Study of ABSK061 and ABSK043
- Where
- Changsha, Changzhi, Chengdu, Guiyang, Hangzhou, Harbin, Jinan, Nanchang, Shanghai, Shenyang, Shijiazhuang, Tianjin, Wuhan, Xiamen, Xi'an, Xiangyang, Xuzhou, Zhengzhou
- Életkor
- 18 év and over
- People
- 202
- Run by
- Abbisko Therapeutics Co, Ltd
See details and how to joinNCT06632262 - 1/2. fázisTaking peopleA Trial of SHR-A2102 With Antitumor Therapy in Advanced Urothelial Carcinoma
- Where
- Guangzhou
- Életkor
- 18 év and over
- People
- 90
- Run by
- Shanghai Hengrui Pharmaceutical Co., Ltd.
See details and how to joinNCT06639347 - No phaseTaking peoplePostoperative Adjuvant Immunotherapy Combined with Radiotherapy Versus Surgery Alone in Locally Advanced UTUC
- Where
- Beijing
- Életkor
- 18 év to 80 év
- People
- 60
- Run by
- Peking University First Hospital
See details and how to joinNCT06598761 - No phaseTaking peopleA Research Protocol for Evaluating the Efficacy of Perfused Chemotherapeutic Agents for Bladder Cancer Based on Organoid Technology
- Where
- Binzhou, Dezhou, Jinan, Jining, Liaocheng, Linyi, Qingdao, Taian, Weifang, Yantai, Zaozhuang, Zibo
- Életkor
- 18 év to 80 év
- People
- 293
- Run by
- Qilu Hospital of Shandong University
See details and how to joinNCT06662071 - No phaseTaking peopleRadical Radiotherapy Versus Radical Surgery for UTUC
- Where
- Beijing
- Életkor
- 18 év to 80 év
- People
- 60
- Run by
- Peking University First Hospital
See details and how to joinNCT06652009 - No phaseTaking peopleRadiotherapy Combined with Systemic Therapy Versus Systemic Therapy for Oligometastatic UTUCs
- Where
- Beijing
- Életkor
- 18 év to 80 év
- People
- 102
- Run by
- Peking University First Hospital
See details and how to joinNCT06652022 - 2. fázisNot yet taking people in KínaA Clinical Trial Evaluating the Efficacy and Safety of Disitamab Vedotin Plus Tislelizumab Combined with Re-TURBT in the Treatment of HER-2-high Expression(2+-3+) Non-muscle Invasive Bladder Cancer At High-risk and Very High-risk.
- Where
- Fuzhou
- Életkor
- 18 év to 85 év
- People
- 40
- Run by
- Fujian Medical University Union Hospital
See details and how to joinNCT06630871